Our Publications

For investors, the journey from capital deployment to exit often feels uncertain and full of obstacles including

11 August 2025

Trump tariff hike to 50% on Indian goods sparks calls for self-reliance

08 August 2025

Dilip Piramal Sells 32% of VIP Industries

08 August 2025

U.S. trade policy is jeopardising the U.S. – India pharma supply chain

08 August 2025

Rising US Tariffs on Indian Imports Threaten Affordable Generic Drug Supply

08 August 2025

Dilip Piramal is exiting, but here’s what it really says about Indian-run empires

08 August 2025

We Sold the Business… Now Who Are We?